Recent publications

• 10th anniversary: The development, implementation, and evaluation of a novel peer-assisted learning (PAL) program April 3, 2026
  CONCLUSION: The outcomes of this report suggest that including various PAL modalities in the didactic pharmacy curriculum can increase student confidence in learning and perceived performance on assessments. The PAL program presented appears feasible, effective, and sustainable.
  Nathaniel M Rickles
• Association of the C-reactive protein-triglyceride glucose index with all-cause and cardiovascular mortality among U.S. adults with metabolic dysfunction-associated steatotic liver disease: a national cohort study April 2, 2026
  No abstract
  Ramin Assempoor
• Efficacy of Oral Arginine as Treatment to Improve Height in Prepubertal Children With Idiopathic Short Stature: A Systematic Review and Meta-Analysis March 30, 2026
  CONCLUSION: Oral arginine administered for 12 months may not affect growth. Well-designed RCTs are required.
  Manuel André Virú-Loza
• It's time to improve antithrombotic therapy! A global perspective for antithrombotic stewardship March 19, 2026
  Antithrombotic drugs are a class of medications with the highest rates of serious and life-threatening adverse events, many of which are preventable with proper knowledge and systems of management. Antithrombotic stewardship is a care model shown to improve outcomes and is gaining traction throughout the world. Stewardship implies a comprehensive system of care employing coordinated, […]
  W Ageno
• Incidence and outcomes of major bleeding among first-time oral factor Xa inhibitor users: multinational observational cohort studies March 18, 2026
  CONCLUSION: Results of this large-scale study indicate that the incidence of major bleeding remains elevated during the first 3 years after initiating FXai treatment and that these bleeding events seemed to be associated with significant mortality.
  Alexander T Cohen
• Ferric Derisomaltose Compared to Iron Sucrose in Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials March 14, 2026
  Background/Objectives: There are conflicting results on the effects of ferric derisomaltose (FDM) vs. iron sucrose (IS) for treatment of iron deficiency anemia (IDA). We systematically assessed the efficacy and safety of these treatments. Methods: We searched Ovid MEDLINE, Web of Science, Pubmed, and Cochrane Central for randomized controlled trials (RCTs) comparing the efficacy and/or safety […]
  Lokman H Tanriverdi
• Utilization and clinical characteristics of patients with type 2 diabetes and chronic kidney disease prescribed finerenone in the United States March 11, 2026
  CONCLUSIONS: Finerenone was primarily prescribed as a pillar of therapy that is used in combination with complementary medications in patients with T2D and CKD, aligning with clinical guidelines and regulatory labeling.
  Csaba P Kovesdy
• Bury my axe in wounded knee: A case of native knee septic arthritis caused by multidrug resistant <em>Lomentospora</em> <em>prolificans</em> March 9, 2026
  A 39-year-old male presenting with swelling and pain in the left knee after traumatic injury was diagnosed with rapidly progressive septic arthritis of the knee due to pan-resistant Lomentospora prolificans. While L. prolificans is an environmental mold, it infrequently causes infection in immunocompetent patients. These hosts most commonly suffer soft tissue or osteoarticular infections following […]
  Weston Carpenter
• Using the ACCP Toolkit to Evolve the PharmD Curriculum March 1, 2026
  CONCLUSION: Using the ACCP Toolkit in the curricular assessment process was effective in identifying areas of curricular overload and informing areas for improvement in a subsequent curricular revision, leading to adjustment of credits and time spent on pharmacotherapy topics within courses.
  Jennifer Luciano
• Short-Term Care Burden After Left Ventricular Assist Device Implantation and Heart Transplant in the United States February 24, 2026
  CONCLUSIONS: Both LVAD and HT had comparable burdens on resources and short-term rehospitalization risk.
  Balaphanidhar Mogga
• Efficacy and harms of polypills for cardiovascular disease prevention: A systematic review and meta-analysis of randomized controlled trials February 20, 2026
  CONCLUSIONS: In primary and secondary prevention settings, polypills had moderate reductions of CV outcomes, small effects on CV risk factors, and small increases of AEs.
  Brian M Portela
• Risk scoring for the primary prevention of cardiovascular disease February 17, 2026
  This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of evaluating and providing cardiovascular disease (CVD) risk scores in adults without prevalent CVD on cardiovascular outcomes, risk factor levels, preventive medication prescribing, and health behaviours.
  Adrian V Hernandez
• The 2025 Invitational Summit on Medicaid Payment for Pharmacist Patient Care Services: Meeting proceedings February 15, 2026
  No abstract
  Marie A Smith
• Compounded Semaglutide and Tirzepatide Products Use Unique Formulations but Efficacy and Safety Largely Unknown February 14, 2026
  CONCLUSION AND RELEVANCE: We found little justification for adding nutrients or docusate sodium to combination subcutaneous semaglutide or tirzepatide products. There is a rationale for adding ondansetron, but evidence for subcutaneous administration is lacking. There is a rationale for fashioning sublingual or ODT formulations, but whether these formulations offer advantages over innovator oral tablets has […]
  Jordyn Belcourt
• Why the Birth Dose Matters for Hepatitis B Vaccination February 12, 2026
  No abstract
  Jennifer E Girotto
• Nonswallowed Kratom-Derived Products: Unlawful Dietary Supplements That Endanger Public Health January 26, 2026
  The Dietary Supplement Health and Education Act of 1994 specified that dietary supplements must be swallowed. In this study, we investigated whether kratom-derived products are being sold to consumers in nonswallowed formulations. Kratom is the fresh or dried leaf powder of the Mitragyna speciosa tree. We identified 49 kratom-derived products being sold in the form […]
  C Michael White
• Harnessing the Power of Artificial Intelligence to Enhance Drug Therapy Research January 14, 2026
  No abstract
  William L Baker
• Concurrent Administration of Triazoles with Chemotherapeutic and/or Immunosuppressant Agents Known to Have Moderate-to-Severe Drug-Drug Interactions in Patients with Hematologic Malignancies Hospitalized for Invasive Aspergillosis January 13, 2026
  CONCLUSIONS: Concurrent administration of triazole with potential PK interactions with CT or IS agents occurred in most HM patients admitted for IA. Choosing alternative antifungals, therapeutic drug monitoring of triazoles or selective ISs, and dosage adjustment of CT/IS agents may mitigate the risk of adverse DDIs. New antifungal agents without serious DDIs with CT and/or […]
  Thomas J Walsh
• Predicting cardiovascular outcomes in elderly patients with acute coronary syndrome: a nomogram approach January 9, 2026
  CONCLUSION: A nomogram successfully predicts MACE risk in older STEMI patients using laboratory, clinical, and procedural parameters. This algorithm may identify vulnerable high-risk patients for more aggressive preventative interventions.
  Hamidreza Soleimani
• PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta-analysis of Randomized Clinical Trials January 7, 2026
  CONCLUSIONS: PCSK9 inhibitors have lower efficacy in reducing lipid levels in HoFH compared with ANGPTL3 inhibitors, with the greatest difference seen in patients with the negative LDLR genotype. Further studies are needed to clarify efficacy across LDLR functional variants.
  Ibadete Bytyçi